BiotechTube
Home/Cadence Neuroscience/Kent
K

Kent

CEO

Cadence Neuroscience

Therapeutic Areas

EpilepsyParkinson's disease

Cadence Neuroscience Pipeline

DrugIndicationPhase
Implantable Neuromodulation SystemDrug-Resistant EpilepsyPre-clinical

Leadership Team at Cadence Neuroscience

D
Doug
CSO
View full Cadence Neuroscience profile